Table 2. Univariate and multivariate analysis.
| Variables | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||
| Age (≥65 vs. <65) | 1.80 (1.22–2.65) | 0.003* | 1.58 (1.07–2.35) | 0.023* | |
| Gender (male vs. female) | 1.01 (0.67–1.53) | 0.952 | |||
| Grade (G3+G4 vs. G1+G2) | 2.30 (1.51–3.50) | <0.001* | |||
| Pathologic stage (III+IV vs. I+II) | 3.47 (2.33–5.17) | <0.001* | 5.77 (2.57–12.93) | <0.001* | |
| T stage (T3+T4 vs. T1+T2) | 2.76 (1.87–4.08) | <0.001* | 0.44 (0.20–0.97) | 0.04* | |
| Hemoglobin result (normal vs. low) | 0.54 (0.35–0.84) | 0.006* | 0.58 (0.37–0.91) | 0.017* | |
| Platelet qualitative result (normal vs. low) | 0.61 (0.37–1.02) | 0.059 | |||
| Serum calcium result (normal vs. low) | 1.25 (0.84–1.85) | 0.265 | |||
| MDEG signature (high risk vs. low risk) | 2.46 (1.63–3.71) | <0.001* | 1.97 (1.25–3.10) | 0.003* | |
*, P value <0.05 was considered as statistically significant.